Regenexx reposted this
Did you know? As of 2025, Regenexx has published almost 40% of the research on the use of bone marrow stem cells for orthopedic conditions. See Dr. Centeno's detailed infographic here:
Regenexx was the first to use stem cells from bone marrow concentrate to treat orthopedic injuries, and we've published roughly half of all worldwide research in their application. Through the Regenexx Corporate Program more than 2.000 employer groups have added the Regenexx benefit onto their self-funded health plan. We use our advanced regenerative technologies to help self-funded employers save up to 70% of their orthopedic healthcare costs by providing a non-surgical, lower cost alternative to roughly 70% of elective orthopedic surgeries. Most importantly, the Regenexx benefit gives employees a non-surgical option in care to help reduce pain and improve function that they wouldn’t have covered otherwise. Regenexxx licenses our injectates and processes to a highly skilled network of physicians. Regenexx lab processing routinely achieves 20x concentration of stem cell-containing bone marrow — far above what non-Regenexx processing can achieve. Learn more about the Regenexx approach and how we help employers take control of their health care spend. Visit www.Regenexx.com and www.Regenexxcorporate.com for more information.
External link for Regenexx
6151 Thornton Dr
Des Moines, Iowa 50321, US
403 Summit Blvd. Suite 201
Broomfield, CO 80021, US
Regenexx exists to help companies ease these increases in health care cost burdens and increases. Thank you to the International Foundation of Employee Benefits Plans for your research. Employers expect their medical plan costs to increase by 8% in 2025. Talk to one of our team members today to help reduce your MSK costs. https://lnkd.in/geww-Puq International Foundation of Employee Benefit Plans (IFEBP)
Regenexx at Work is the Corporate Program's monthly newsletter delivering the latest on the state of musculoskeletal care, timely topics, and examples of how the Regenexx Corporate Program continues to save employers up to 70% on their MSK costs while providing their employees a non-surgical option in care.
Dr. Chris Centeno, Chief Medical Officer and founder of Regenexx, discusses the Regenexx Corporate Program utilization system and InterQual integration for 2025. The Regenexx Corporate Program provides members with an option in care that can reduce the cost of individual orthopedic surgeries by up to 70%. The Regenexx approach addresses a critical gap between non-surgical treatments such as physical therapy and orthopedic surgery. By providing an intermediary option, we help reduce the overuse and misuse of orthopedic surgeries, empowering patients to receive optimal care. For more information about the Regenexx Corporate program and adding the Regenexx benefit to self-funded health plans reach out to one of our Corporate Program sales team members or visit: https://lnkd.in/gt3yVTUe #HealthcareInnovation #Regenexx #InterventionalOrthopedics #20thanniversary #20years #EmployeeBenefits
Celebrating 20 years of innovation and transformation in healthcare, Regenexx and its founder, Chris Centeno, M.D., have paved the way in interventional orthopedics for 2 decades. The Regenexx Corporate Program extends this impact to covered lives, with a focus on giving employees a better option in care than orthopedic surgery while simultaneously improving employers' bottom line. It's only the beginning! For insights on interventional orthobiologics, visit www.regenexx.com. To explore the Regenexx Corporate Program, head to www.regenexxcorporate.com. #HealthcareInnovation #Regenexx #InterventionalOrthopedics #20thanniversary Wayne Schellhammer Jason Hellickson
20 years ago, I founded Regenexx. In that time, I've seen countless companies flash bright and disappear in this space, while Regenexx has remained steadfast in its singular mission to make interventional orthobiologics the standard of care alternative to orthopedic surgery. In 2005, I began using both culture-expanded bone marrow MSCs and bone marrow concentrate with PRP. We spent two years doing this for free as part of an IRB-approved study. Since that time, we tested regulatory waters, defined a new field of interventional orthobiologics, and ultimately ended up with more than 3,500 corporate clients who want to use IO to help their employees avoid more invasive surgeries. We've tracked >70,000 patients in a registry, launched two FDA approval trials (one now in phase 2 and one in pre-IND), submitted more patents than I can count, helped launch two 510-K approved devices, and have more than 100 clinical sites which will likely grow to 200 in the next 12 months. We have published dozens of peer-reviewed papers and now even count one of my mentors (Phillippe Hernigou) as part of our team! Thank you to all the employees, scientists, physicians, fundraisers, and others who have helped to take Regenexx from an idea to reality!
Just one example of the variety of self-funded clients the Regenexx Corporate Program serves to offer employees a non-surgical solution to their orthopedic pain. Regenexx will be attending the TCA conference March 15th-18th to spread the word to attendees about this incredible benefit! #truckloadstrong #employeebenefits Truckload Carriers Association (TCA)
regenexx for health plans | ortho/msk benefit solution provider | cost reduction strategies for self-funded health plans
Regenexx will be at Truckload Carriers Association (TCA) Truckload 2025! Looking forward to connecting with more industry leaders. We currently serve thousands of individuals in the trucking/logistics industry helping them avoid surgery and get back on the road faster.
Regenexx reposted this
The IO literature for knee OA is exploding. It's time for major societies to issue guidelines that align with the literature supporting PRP. See https://lnkd.in/gZNG3tR5
The Regenexx non-surgical approach can be added to a self-funded health plan through the Regenexx Corporate Program at zero cost and save self-funded employers up to 70% on their MSK spend all while offering employees a better option in care. Learn More: https://lnkd.in/gnS4GwJN